Knockdown of MALAT1 inhibits LTBP3 transcription and TGF-β secretion in MSCs from the bone marrow of myeloma patients, whereas overexpression of MALAT1 increases LTBP3 transcription and TGF-β secretion in MSCs from healthy donors. Here, MALAT1 is linked to plasma cell myeloma.